Cargando…
Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions
BACKGROUND: Hsp90 (heat shock protein90) is a chaperone protein essential for preserving and regulating the function of various cellular proteins. Elevated Hsp90 expression seems to be a trait of breast cancer and may be an integral part of the coping mechanisms that cancer cells exhibit vis-à-vis s...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912866/ https://www.ncbi.nlm.nih.gov/pubmed/20602789 http://dx.doi.org/10.1186/1471-2407-10-353 |
_version_ | 1782184638824841216 |
---|---|
author | Zagouri, Flora Sergentanis, Theodoros N Nonni, Afrodite Papadimitriou, Christos A Michalopoulos, Nikolaos V Domeyer, Philip Theodoropoulos, George Lazaris, Andreas Patsouris, Effstratios Zogafos, Eleni Pazaiti, Anastazia Zografos, George C |
author_facet | Zagouri, Flora Sergentanis, Theodoros N Nonni, Afrodite Papadimitriou, Christos A Michalopoulos, Nikolaos V Domeyer, Philip Theodoropoulos, George Lazaris, Andreas Patsouris, Effstratios Zogafos, Eleni Pazaiti, Anastazia Zografos, George C |
author_sort | Zagouri, Flora |
collection | PubMed |
description | BACKGROUND: Hsp90 (heat shock protein90) is a chaperone protein essential for preserving and regulating the function of various cellular proteins. Elevated Hsp90 expression seems to be a trait of breast cancer and may be an integral part of the coping mechanisms that cancer cells exhibit vis-à-vis stress. This manuscript tries to examine the immunohistochemical expression of Hsp90 all along the continuum of breast ductal lesions encompassing ductal hyperplasia without atypia (DHWithoutA), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). METHODS: Tissue specimens were taken from 30 patients with DHWithoutA, 31 patients with ADH, 51 with DCIS and 51 with IDC. Immunohistochemical assessment of Hsp90 was performed both in the lesion and the adjacent normal breast ducts and lobules; the latter serving as control. Concerning Hsp90 assessment the percentage of positive cells and the intensity were separately analyzed. Subsequently, the Allred score was calculated. Post hoc analysis on the correlations between Hsp90 Allred score and possible predictors (grade, nodal status, tumor size, ER Allred score, PR Allred score, c-erbB-2 status and triple negative status) was conducted in IDC. RESULTS: Hsp90 exhibited mainly cytoplasmic immunoreactivity. Hsp90 Allred score exhibited an increasing trend along the continuum of breast ductal lesions (Spearman's rho = 0.169, p = 0.031). Compared to the adjacent normal ducts and lobules, no statistically significant differences were noted in DHwithoutA, ADH and DCIS. Hsp90 expression (intensity, positive cells, Allred score) was higher in IDC, compared to the adjacent normal tissue. Higher Hsp90 expression was observed in grade 2/3 IDCs (borderline association) and tumors of larger size. At the univariable analysis, higher Hsp90 expression was associated with higher ER Allred score, PR Allred score and c-erbB-2 positivity in IDC. Triple-negative IDCs exhibited significantly lower Hsp90 expression. The multivariable logistic regression model revealed that between the three markers, solely ER Allred score and c-erbB-2 positivity were independently associated with higher Hsp90 expression in IDC. CONCLUSION: The above point to significant variability in Hsp90 expression with significant implications upon the effectiveness and limitations of anti-Hsp90 drugs. |
format | Text |
id | pubmed-2912866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29128662010-07-31 Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions Zagouri, Flora Sergentanis, Theodoros N Nonni, Afrodite Papadimitriou, Christos A Michalopoulos, Nikolaos V Domeyer, Philip Theodoropoulos, George Lazaris, Andreas Patsouris, Effstratios Zogafos, Eleni Pazaiti, Anastazia Zografos, George C BMC Cancer Research Article BACKGROUND: Hsp90 (heat shock protein90) is a chaperone protein essential for preserving and regulating the function of various cellular proteins. Elevated Hsp90 expression seems to be a trait of breast cancer and may be an integral part of the coping mechanisms that cancer cells exhibit vis-à-vis stress. This manuscript tries to examine the immunohistochemical expression of Hsp90 all along the continuum of breast ductal lesions encompassing ductal hyperplasia without atypia (DHWithoutA), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). METHODS: Tissue specimens were taken from 30 patients with DHWithoutA, 31 patients with ADH, 51 with DCIS and 51 with IDC. Immunohistochemical assessment of Hsp90 was performed both in the lesion and the adjacent normal breast ducts and lobules; the latter serving as control. Concerning Hsp90 assessment the percentage of positive cells and the intensity were separately analyzed. Subsequently, the Allred score was calculated. Post hoc analysis on the correlations between Hsp90 Allred score and possible predictors (grade, nodal status, tumor size, ER Allred score, PR Allred score, c-erbB-2 status and triple negative status) was conducted in IDC. RESULTS: Hsp90 exhibited mainly cytoplasmic immunoreactivity. Hsp90 Allred score exhibited an increasing trend along the continuum of breast ductal lesions (Spearman's rho = 0.169, p = 0.031). Compared to the adjacent normal ducts and lobules, no statistically significant differences were noted in DHwithoutA, ADH and DCIS. Hsp90 expression (intensity, positive cells, Allred score) was higher in IDC, compared to the adjacent normal tissue. Higher Hsp90 expression was observed in grade 2/3 IDCs (borderline association) and tumors of larger size. At the univariable analysis, higher Hsp90 expression was associated with higher ER Allred score, PR Allred score and c-erbB-2 positivity in IDC. Triple-negative IDCs exhibited significantly lower Hsp90 expression. The multivariable logistic regression model revealed that between the three markers, solely ER Allred score and c-erbB-2 positivity were independently associated with higher Hsp90 expression in IDC. CONCLUSION: The above point to significant variability in Hsp90 expression with significant implications upon the effectiveness and limitations of anti-Hsp90 drugs. BioMed Central 2010-07-05 /pmc/articles/PMC2912866/ /pubmed/20602789 http://dx.doi.org/10.1186/1471-2407-10-353 Text en Copyright ©2010 Zagouri et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zagouri, Flora Sergentanis, Theodoros N Nonni, Afrodite Papadimitriou, Christos A Michalopoulos, Nikolaos V Domeyer, Philip Theodoropoulos, George Lazaris, Andreas Patsouris, Effstratios Zogafos, Eleni Pazaiti, Anastazia Zografos, George C Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions |
title | Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions |
title_full | Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions |
title_fullStr | Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions |
title_full_unstemmed | Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions |
title_short | Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions |
title_sort | hsp90 in the continuum of breast ductal carcinogenesis: evaluation in precursors, preinvasive and ductal carcinoma lesions |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912866/ https://www.ncbi.nlm.nih.gov/pubmed/20602789 http://dx.doi.org/10.1186/1471-2407-10-353 |
work_keys_str_mv | AT zagouriflora hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT sergentanistheodorosn hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT nonniafrodite hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT papadimitriouchristosa hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT michalopoulosnikolaosv hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT domeyerphilip hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT theodoropoulosgeorge hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT lazarisandreas hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT patsouriseffstratios hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT zogafoseleni hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT pazaitianastazia hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions AT zografosgeorgec hsp90inthecontinuumofbreastductalcarcinogenesisevaluationinprecursorspreinvasiveandductalcarcinomalesions |